Now I have all the information needed to give a thorough answer. Here's what I found:
Acyclovir Cream + Noxa Cream in Herpes Zoster: Key Points
What is Noxa Cream?
Noxa Cream is an Indian brand containing ozenoxacin 1% w/w - a quinolone-class topical antibacterial agent (not antiviral, not antifungal). It is used to treat bacterial skin infections such as impetigo and infected wounds.
Can they be used together?
Short answer: There is no standard indication for combining them in herpes zoster, and the combination has limited clinical rationale. Here's the reasoning:
1. Acyclovir cream is poorly effective for herpes zoster
According to Harrison's Principles of Internal Medicine (22E, 2025):
"Topical acyclovir, penciclovir, and docosanol are approved for treatment of orolabial herpes but are much less effective than the oral drugs."
Rosen's Emergency Medicine states:
"Systemic therapy is the standard of care (unlike HSV, topical antivirals have little effect [in herpes zoster])."
Goldman-Cecil Medicine adds:
"Topical antiviral creams such as penciclovir and acyclovir do not significantly shorten the course of herpes simplex."
In herpes zoster specifically, topical acyclovir cream is not recommended as the primary treatment. The standard of care is oral antiviral therapy - acyclovir 800 mg 5x/day x 7-10 days, or better yet valacyclovir 1g TID x 7 days, or famciclovir 500 mg TID x 7 days.
2. Ozenoxacin (Noxa cream) has no antiviral activity
Ozenoxacin works against bacteria (Gram-positive cocci, MRSA, etc.) by inhibiting bacterial DNA gyrase and topoisomerase IV. It has no activity against VZV (varicella-zoster virus). Using it as an antiviral agent in zoster would be ineffective.
3. When could ozenoxacin (Noxa) be relevant in a zoster patient?
The only scenario where an antibacterial topical like Noxa cream could be considered alongside acyclovir (oral, not cream) is if the zoster lesions have developed secondary bacterial superinfection (e.g., impetiginization with S. aureus or Streptococcus). In that case:
- Oral antivirals remain the backbone of VZV treatment
- Topical ozenoxacin (Noxa) could address the bacterial superinfection on the skin
However, in most cases of superinfection, oral antibiotics (e.g., cefalexin or amoxicillin-clavulanate) are preferred over topical agents, especially if the infection is moderate or severe.
Summary Table
| Agent | Class | Role in Herpes Zoster |
|---|
| Acyclovir cream | Topical antiviral | Ineffective for zoster - use oral antiviral instead |
| Noxa cream (ozenoxacin 1%) | Topical antibacterial | No antiviral effect; may be considered only for bacterial superinfection |
| Oral acyclovir / valacyclovir / famciclovir | Systemic antiviral | This is the correct treatment for herpes zoster |
Bottom Line
- Do not rely on acyclovir cream for herpes zoster - it is clinically inadequate; oral antivirals are mandatory.
- Noxa cream (ozenoxacin) is a bacterial treatment with no role against the zoster virus itself.
- The two creams are pharmacologically distinct (antiviral vs antibacterial) and combining them topically has no documented benefit for VZV infection.
- If bacterial superinfection is present on top of zoster lesions, ozenoxacin cream could be added as an adjunct to oral antiviral therapy - but this should be based on clinical assessment.